SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mader R, Sarzi-Puttini P, Atzeni F, Olivieri I, Pappone N, Verlaan JJ, et al. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis [review]. Rheumatology (Oxford) 2009; 48: 147881.
  • 2
    Kiss C, Szilagyi M, Paksy A, Poor G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case control study. Rheumatology (Oxford) 2002; 41: 2730.
  • 3
    Mader R, Novofestovski I, Adawi M, Lavi I. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum 2009; 38: 3615.
  • 4
    Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G, and the CaRRDs Study Group. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 2011; 31: 70512.
  • 5
    Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R, et al. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 2012; 38: 497505.
  • 6
    Weinfeld RM, Olson PN, Maki DD, Griffiths HG. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 1997; 26: 2225.
  • 7
    Kiss C, O'Neill TW, Mituszova M, Szilagyi M, Poor G. The prevalence of diffuse idiopathic skeletal hyperostosis in a population-based study in Hungary. Scand J Rheumatol 2002; 31: 2269.
  • 8
    Pappone N, Lubrano E, Esposito-del Puente A, D'Angelo S, Di Girolamo C, Del Puente A. Prevalence of diffuse idiopathic skeletal hyperostosis in a female Italian population. Clin Exp Rheumatol 2005; 23: 1234.
  • 9
    Julkunen H, Knekt P, Aromaa A. Spondylosis deformans and diffuse idiopathic skeletal hyperostosis (DISH) in Finland. Scand J Rheumatol 1981; 10: 193203.
  • 10
    Westerveld LA, van Ufford HM, Verlaan JJ, Oner FC. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in The Netherlands. J Rheumatol 2008; 35: 16358.
  • 11
    Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, et al. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken) 2012. E-pub ahead of print.
  • 12
    Krabbe KS, Pederesen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 68799.
  • 13
    Vezyroglou G, Mitropoulos A, Kyriazis N, Antoniadis C. A metabolic syndrome in diffuse idiopathic skeletal hyperostos: a controlled study. J Rheumatol 1996; 23: 6726.
  • 14
    Sencan D, Elden H, Nacitrahan V, Sencan M, Kaptanoglu E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int 2005; 25: 51821.
  • 15
    Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 15228.